Inhibition of mTOR-kinase destabilizes MYCN and is a potential therapy for MYCN-dependent tumors
Lynsey Vaughan(University of Manchester), Louis Chesler(Institute of Cancer Research)
Cited by 57
Related Papers
Inhibition of Phosphatidylinositol 3-Kinase Destabilizes Mycn Protein and Blocks Malignant Progression in Neuroblastoma
|Cancer Research|2006|198
Pleiotropic role for<i>MYCN</i>in medulloblastoma
|Genes & Development|2010|174